CIBC Private Wealth Group
IBRX icon

CIBC Private Wealth Group’s ImmunityBio IBRX Stock Holding History

CIBC Private Wealth Group’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$18K Buy
9,113
+5,613
+160% +$12.7K ﹤0.01% 2199
2025
Q3 		$8.61K Sell
3,500
-2,500
-42% -$6.44K ﹤0.01% 2435
2025
Q2 		$15.8K Buy
6,000
+2,500
+71% +$6.72K ﹤0.01% 2103
2025
Q1 		$8.47K Buy
+3,500
New +$10.6K ﹤0.01% 2291

Other funds holding IBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

CIBC Private Wealth Group's IBRX Position: Q4 2025 in Review

CIBC Private Wealth Group increased its ImmunityBio (IBRX) stake by 160% in Q4 2025, buying an estimated $12.7K and bringing the position to 9,113 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #2199.

CIBC Private Wealth Group first reported a position in IBRX in Q1 2025 and has held it in 4 quarters since. 276 funds tracked by Wall St. Rank hold IBRX as of Q4 2025.

  • CIBC Private Wealth Group held 9,113 shares of ImmunityBio worth $18K as of Q4 2025.
  • CIBC Private Wealth Group bought 5,613 ImmunityBio shares in Q4 2025, an estimated $12.7K.
  • ImmunityBio made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2199 holding.
  • CIBC Private Wealth Group first reported a position in ImmunityBio in Q1 2025 and has held it in 4 quarters since.
  • 276 funds tracked by Wall St. Rank held ImmunityBio as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.